Mannkind (MNKD) Profit After Tax Growth (3y) (2013 - 2026)
Mannkind (MNKD) Profit After Tax Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 9.53% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 38.43% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 13.80% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -27.65% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 70.25% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Mannkind | 1.23 Bn | 1.10 Bn | 82.66 Mn | -19.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.27% |
| Dec 31, 2025 | 3.86% |
| Sep 30, 2025 | 36.68% |
| Jun 30, 2025 | 26.47% |
| Mar 31, 2025 | 35.83% |
| Dec 31, 2024 | 31.34% |
| Sep 30, 2024 | 66.43% |
| Jun 30, 2024 | 61.58% |
| Mar 31, 2024 | 41.33% |
| Dec 31, 2023 | 27.10% |
| Sep 30, 2023 | 29.12% |
| Jun 30, 2023 | 19.92% |
| Mar 31, 2023 | -1.66% |
| Dec 31, 2022 | -7.96% |
| Sep 30, 2022 | -11.65% |
| Jun 30, 2022 | -32.82% |
| Mar 31, 2022 | -20.43% |
| Dec 31, 2021 | -42.02% |
| Sep 30, 2021 | 43.21% |
| Jun 30, 2021 | -16.14% |